JP6084172B2 - 酸化感受性材料の統合的な触媒による保護 - Google Patents
酸化感受性材料の統合的な触媒による保護 Download PDFInfo
- Publication number
- JP6084172B2 JP6084172B2 JP2013558170A JP2013558170A JP6084172B2 JP 6084172 B2 JP6084172 B2 JP 6084172B2 JP 2013558170 A JP2013558170 A JP 2013558170A JP 2013558170 A JP2013558170 A JP 2013558170A JP 6084172 B2 JP6084172 B2 JP 6084172B2
- Authority
- JP
- Japan
- Prior art keywords
- sensor
- graft
- porous
- indicator
- protective coating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000463 material Substances 0.000 title claims description 95
- 238000007254 oxidation reaction Methods 0.000 title claims description 56
- 230000003647 oxidation Effects 0.000 title claims description 55
- 230000003197 catalytic effect Effects 0.000 title description 14
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 108
- 229910052751 metal Inorganic materials 0.000 claims description 94
- 239000002184 metal Substances 0.000 claims description 94
- 239000003642 reactive oxygen metabolite Substances 0.000 claims description 73
- 238000001727 in vivo Methods 0.000 claims description 56
- 229910052697 platinum Inorganic materials 0.000 claims description 51
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 49
- 238000000034 method Methods 0.000 claims description 40
- 239000010410 layer Substances 0.000 claims description 37
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 36
- 229910052709 silver Inorganic materials 0.000 claims description 36
- 239000004332 silver Substances 0.000 claims description 36
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 31
- 239000008103 glucose Substances 0.000 claims description 31
- 239000011253 protective coating Substances 0.000 claims description 30
- 230000001681 protective effect Effects 0.000 claims description 28
- 238000000576 coating method Methods 0.000 claims description 26
- 238000004544 sputter deposition Methods 0.000 claims description 25
- 239000011248 coating agent Substances 0.000 claims description 24
- 229910052763 palladium Inorganic materials 0.000 claims description 24
- 229920000642 polymer Polymers 0.000 claims description 24
- 230000015556 catabolic process Effects 0.000 claims description 23
- 238000006731 degradation reaction Methods 0.000 claims description 23
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 23
- 229910052737 gold Inorganic materials 0.000 claims description 22
- 239000010931 gold Substances 0.000 claims description 22
- 230000004888 barrier function Effects 0.000 claims description 21
- 239000012491 analyte Substances 0.000 claims description 20
- 229910044991 metal oxide Inorganic materials 0.000 claims description 20
- 150000004706 metal oxides Chemical class 0.000 claims description 20
- 239000000956 alloy Substances 0.000 claims description 19
- 229910045601 alloy Inorganic materials 0.000 claims description 19
- 230000006378 damage Effects 0.000 claims description 18
- 208000005422 Foreign-Body reaction Diseases 0.000 claims description 17
- 206010061218 Inflammation Diseases 0.000 claims description 17
- 239000003054 catalyst Substances 0.000 claims description 16
- 229920002521 macromolecule Polymers 0.000 claims description 14
- 230000005855 radiation Effects 0.000 claims description 14
- 239000007800 oxidant agent Substances 0.000 claims description 13
- 230000002757 inflammatory effect Effects 0.000 claims description 12
- 241001465754 Metazoa Species 0.000 claims description 10
- 230000028709 inflammatory response Effects 0.000 claims description 10
- 230000004054 inflammatory process Effects 0.000 claims description 9
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims description 8
- 230000007774 longterm Effects 0.000 claims description 7
- 230000008859 change Effects 0.000 claims description 6
- 230000006866 deterioration Effects 0.000 claims description 4
- 238000012544 monitoring process Methods 0.000 claims description 4
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical group OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 claims description 4
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims 1
- 230000006335 response to radiation Effects 0.000 claims 1
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 168
- 239000007943 implant Substances 0.000 description 34
- 239000000178 monomer Substances 0.000 description 19
- 230000006870 function Effects 0.000 description 18
- 239000000523 sample Substances 0.000 description 18
- 230000000694 effects Effects 0.000 description 16
- 150000002739 metals Chemical class 0.000 description 16
- 239000000243 solution Substances 0.000 description 13
- 239000000126 substance Substances 0.000 description 12
- 210000001519 tissue Anatomy 0.000 description 12
- 238000000354 decomposition reaction Methods 0.000 description 10
- 230000035876 healing Effects 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 10
- 239000012528 membrane Substances 0.000 description 10
- WYTGDNHDOZPMIW-RCBQFDQVSA-N alstonine Natural products C1=CC2=C3C=CC=CC3=NC2=C2N1C[C@H]1[C@H](C)OC=C(C(=O)OC)[C@H]1C2 WYTGDNHDOZPMIW-RCBQFDQVSA-N 0.000 description 9
- 238000001514 detection method Methods 0.000 description 9
- 238000009792 diffusion process Methods 0.000 description 9
- 238000001465 metallisation Methods 0.000 description 9
- 230000008901 benefit Effects 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 238000010586 diagram Methods 0.000 description 8
- 239000001301 oxygen Substances 0.000 description 8
- 229910052760 oxygen Inorganic materials 0.000 description 8
- 239000011241 protective layer Substances 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 239000010408 film Substances 0.000 description 7
- 238000002513 implantation Methods 0.000 description 7
- 230000001590 oxidative effect Effects 0.000 description 7
- 239000011148 porous material Substances 0.000 description 7
- 230000029663 wound healing Effects 0.000 description 7
- 208000027418 Wounds and injury Diseases 0.000 description 6
- 230000002411 adverse Effects 0.000 description 6
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical group OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 description 6
- 238000013461 design Methods 0.000 description 6
- 125000006575 electron-withdrawing group Chemical group 0.000 description 6
- 229920001480 hydrophilic copolymer Polymers 0.000 description 6
- 230000008439 repair process Effects 0.000 description 6
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 5
- 230000000670 limiting effect Effects 0.000 description 5
- 150000002978 peroxides Chemical class 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 230000004044 response Effects 0.000 description 5
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 4
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 4
- 206010052428 Wound Diseases 0.000 description 4
- 125000003118 aryl group Chemical group 0.000 description 4
- 125000004429 atom Chemical group 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 238000004377 microelectronic Methods 0.000 description 4
- 210000000440 neutrophil Anatomy 0.000 description 4
- -1 oxygen radical species Chemical class 0.000 description 4
- CMFNMSMUKZHDEY-UHFFFAOYSA-N peroxynitrous acid Chemical compound OON=O CMFNMSMUKZHDEY-UHFFFAOYSA-N 0.000 description 4
- 238000001878 scanning electron micrograph Methods 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 230000000451 tissue damage Effects 0.000 description 4
- 231100000827 tissue damage Toxicity 0.000 description 4
- ORZHVTYKPFFVMG-UHFFFAOYSA-N xylenol orange Chemical compound OC(=O)CN(CC(O)=O)CC1=C(O)C(C)=CC(C2(C3=CC=CC=C3S(=O)(=O)O2)C=2C=C(CN(CC(O)=O)CC(O)=O)C(O)=C(C)C=2)=C1 ORZHVTYKPFFVMG-UHFFFAOYSA-N 0.000 description 4
- 241000282412 Homo Species 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000013068 control sample Substances 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 238000012377 drug delivery Methods 0.000 description 3
- 210000003722 extracellular fluid Anatomy 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 230000009545 invasion Effects 0.000 description 3
- 238000002386 leaching Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 230000000399 orthopedic effect Effects 0.000 description 3
- 230000004792 oxidative damage Effects 0.000 description 3
- 238000010525 oxidative degradation reaction Methods 0.000 description 3
- 210000003491 skin Anatomy 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 238000007920 subcutaneous administration Methods 0.000 description 3
- 238000002054 transplantation Methods 0.000 description 3
- 210000000707 wrist Anatomy 0.000 description 3
- 229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 2
- 102000004020 Oxygenases Human genes 0.000 description 2
- 108090000417 Oxygenases Proteins 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- 238000000149 argon plasma sintering Methods 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 230000008512 biological response Effects 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 230000000254 damaging effect Effects 0.000 description 2
- 238000010502 deborylation reaction Methods 0.000 description 2
- 230000000593 degrading effect Effects 0.000 description 2
- 238000000151 deposition Methods 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 239000003269 fluorescent indicator Substances 0.000 description 2
- 239000011888 foil Substances 0.000 description 2
- 150000002390 heteroarenes Chemical class 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 150000002576 ketones Chemical group 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000004904 shortening Methods 0.000 description 2
- 238000005477 sputtering target Methods 0.000 description 2
- 150000003457 sulfones Chemical group 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical group OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 1
- VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical compound [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 description 1
- 206010070245 Foreign body Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- RHLLDTPGTFRJDJ-UHFFFAOYSA-N OCl.OCl Chemical compound OCl.OCl RHLLDTPGTFRJDJ-UHFFFAOYSA-N 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 150000001299 aldehydes Chemical group 0.000 description 1
- RGCKGOZRHPZPFP-UHFFFAOYSA-N alizarin Chemical compound C1=CC=C2C(=O)C3=C(O)C(O)=CC=C3C(=O)C2=C1 RGCKGOZRHPZPFP-UHFFFAOYSA-N 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- DYBXVITUBPGBBW-UHFFFAOYSA-N anthracen-1-ylboronic acid Chemical compound C1=CC=C2C=C3C(B(O)O)=CC=CC3=CC2=C1 DYBXVITUBPGBBW-UHFFFAOYSA-N 0.000 description 1
- 125000005428 anthryl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C3C(*)=C([H])C([H])=C([H])C3=C([H])C2=C1[H] 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 150000001543 aryl boronic acids Chemical group 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 125000005621 boronate group Chemical group 0.000 description 1
- 125000005620 boronic acid group Chemical group 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical group 0.000 description 1
- 230000007248 cellular mechanism Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 239000004035 construction material Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 230000005786 degenerative changes Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 150000002148 esters Chemical group 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000013213 extrapolation Methods 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 210000003195 fascia Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 125000004438 haloalkoxy group Chemical group 0.000 description 1
- 125000001188 haloalkyl group Chemical group 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 150000002367 halogens Chemical group 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 150000002433 hydrophilic molecules Chemical class 0.000 description 1
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000003960 inflammatory cascade Effects 0.000 description 1
- 238000013101 initial test Methods 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 125000005647 linker group Chemical group 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 150000004767 nitrides Chemical class 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000037368 penetrate the skin Effects 0.000 description 1
- 238000007539 photo-oxidation reaction Methods 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 238000002294 plasma sputter deposition Methods 0.000 description 1
- 238000000717 platinum sputter deposition Methods 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 230000036515 potency Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000008458 response to injury Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 108010038196 saccharide-binding proteins Proteins 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical group 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- 150000003462 sulfoxides Chemical group 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/07—Endoradiosondes
- A61B5/076—Permanent implantation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/1459—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters invasive, e.g. introduced into the body by a catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/02—Details of sensors specially adapted for in-vivo measurements
- A61B2562/028—Microscale sensors, e.g. electromechanical sensors [MEMS]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/16—Details of sensor housings or probes; Details of structural supports for sensors
- A61B2562/162—Capsule shaped sensor housings, e.g. for swallowing or implantation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/18—Shielding or protection of sensors from environmental influences, e.g. protection from mechanical damage
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Medical Informatics (AREA)
- Surgery (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Optics & Photonics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Emergency Medicine (AREA)
- Materials For Medical Uses (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Electrotherapy Devices (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161452893P | 2011-03-15 | 2011-03-15 | |
| US61/452,893 | 2011-03-15 | ||
| US201161527368P | 2011-08-25 | 2011-08-25 | |
| US61/527,368 | 2011-08-25 | ||
| PCT/US2012/029209 WO2012125814A2 (en) | 2011-03-15 | 2012-03-15 | Integrated catalytic protection of oxidation sensitive materials |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014514033A JP2014514033A (ja) | 2014-06-19 |
| JP2014514033A5 JP2014514033A5 (enExample) | 2016-09-15 |
| JP6084172B2 true JP6084172B2 (ja) | 2017-02-22 |
Family
ID=46828999
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013558170A Expired - Fee Related JP6084172B2 (ja) | 2011-03-15 | 2012-03-15 | 酸化感受性材料の統合的な触媒による保護 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US9681824B2 (enExample) |
| EP (1) | EP2685884B1 (enExample) |
| JP (1) | JP6084172B2 (enExample) |
| KR (1) | KR101959067B1 (enExample) |
| CN (1) | CN103533884B (enExample) |
| AU (1) | AU2012229109A1 (enExample) |
| CA (1) | CA2830432C (enExample) |
| SG (1) | SG193496A1 (enExample) |
| TW (1) | TWI592663B (enExample) |
| WO (1) | WO2012125814A2 (enExample) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8283602B2 (en) | 2007-03-19 | 2012-10-09 | Augustine Temperature Management LLC | Heating blanket |
| US10201935B2 (en) | 2007-03-19 | 2019-02-12 | Augustine Temperature Management LLC | Electric heating pad |
| US20150366367A1 (en) | 2007-03-19 | 2015-12-24 | Augustine Temperature Management LLC | Electric heating pad with electrosurgical grounding |
| AU2012229109A1 (en) | 2011-03-15 | 2013-10-10 | Senseonics, Incorporated | Integrated catalytic protection of oxidation sensitive materials |
| US20140088383A1 (en) * | 2012-09-14 | 2014-03-27 | Senseonics, Incorporated | Integrated catalytic protection of oxidation sensitive materials |
| CA2896749A1 (en) | 2012-12-28 | 2014-07-03 | Senseonics, Incorporated | Analyte permeable membrane systems for oxidative and optical stability |
| US11109779B2 (en) | 2012-12-28 | 2021-09-07 | Senseonics, Incorporated | Chemical modification of analyte permeable membrane for enhanced oxidative stability |
| DK3035849T3 (da) | 2013-08-21 | 2019-09-30 | Senseonics Inc | Lægemiddeleluering til beskyttelse in vivo af biosensor-analysander |
| US9963556B2 (en) | 2013-09-18 | 2018-05-08 | Senseonics, Incorporated | Critical point drying of hydrogels in analyte sensors |
| NZ722834A (en) | 2014-02-19 | 2019-03-29 | Mallinckrodt Hospital Products Ip Ltd | Systems and methods for compensating long term sensitivity drift of electrochemical gas sensors exposed to nitric oxide |
| US9962122B2 (en) | 2014-04-10 | 2018-05-08 | Augustine Temperature Management LLC | Underbody warming systems |
| US10206248B2 (en) | 2014-11-13 | 2019-02-12 | Augustine Temperature Management LLC | Heated underbody warming systems with electrosurgical grounding |
| WO2017087408A1 (en) | 2015-11-16 | 2017-05-26 | HHeLI, LLC | A process for synthesis and surface- functionalization of acidified metal oxide materials for use in energy storage, catalytic, photovoltaic, and sensor applications |
| US20180000997A1 (en) * | 2016-06-29 | 2018-01-04 | Berlock Aps | Implantable Device Having an Outer Surface Comprising Gold and Its Use as an Anti-Migration Device |
| US10869624B2 (en) | 2016-10-18 | 2020-12-22 | Senseonics, Incorporated | Real time assessement of sensor performance and prediction of the end of the functional life of an implanted sensor |
| WO2018093945A1 (en) | 2016-11-15 | 2018-05-24 | Hheli, Llc. | A surface-functionalized, acidified metal oxide material in an acidified electrolyte system or an acidified electrode system |
| CN110870113B (zh) * | 2017-04-10 | 2023-12-01 | 氢氦锂有限公司 | 具有新型组分的电池 |
| EP3612094B1 (en) | 2017-04-19 | 2022-04-06 | Senseonics, Incorporated | Detecting and correcting for changes to an analyte indicator |
| US12369824B2 (en) | 2017-04-19 | 2025-07-29 | Senseonics, Incorporated | Detecting and correcting for interference in an analyte monitoring system |
| CN117012944A (zh) | 2017-05-17 | 2023-11-07 | 氢氦锂有限公司 | 阴极活性材料和阴极 |
| KR102721312B1 (ko) | 2017-05-17 | 2024-10-24 | 에이치헬리, 엘엘씨 | 산성화 캐소드와 리튬 애노드를 가진 배터리 |
| US10978731B2 (en) | 2017-06-21 | 2021-04-13 | HHeLI, LLC | Ultra high capacity performance battery cell |
| CA3076501A1 (en) | 2017-09-22 | 2019-03-28 | HHeLI, LLC | Construction of ultra high capacity performance battery cells |
| WO2019108641A1 (en) * | 2017-11-28 | 2019-06-06 | Senseonics, Incorporated | Analyte indicator integrated with a catalytically active material |
| KR102098078B1 (ko) * | 2018-07-13 | 2020-04-08 | 주식회사 엔게인 | 수화겔 및 이를 포함하는 글루코스 센서 |
| KR102632805B1 (ko) | 2018-09-10 | 2024-02-02 | 에이치헬리, 엘엘씨 | 초고용량 성능 배터리 셀의 사용 방법 |
| WO2020092897A1 (en) * | 2018-11-02 | 2020-05-07 | Senseonics, Incorporated | Drug eluting matrix on analyte indicator |
| US11826143B2 (en) * | 2018-12-05 | 2023-11-28 | Senseonics, Incorporated | Reduction of in vivo analyte signal degradation using multiple metals |
| US10765580B1 (en) | 2019-03-27 | 2020-09-08 | Augustine Biomedical And Design, Llc | Patient securement system for the surgical trendelenburg position |
| CA3137757A1 (en) | 2019-05-08 | 2020-11-12 | Senseonics, Incorporated | Mediation of in vivo analyte signal degradation |
| US11963761B2 (en) | 2019-05-16 | 2024-04-23 | Senseonics, Incorporated | Mediation of in vivo analyte signal degradation |
| US12278342B2 (en) | 2019-06-12 | 2025-04-15 | HHeLI, LLC | Alkaline and acidified metal oxide blended active materials |
| US20200395598A1 (en) | 2019-06-12 | 2020-12-17 | HHeLI, LLC | Blended active materials for battery cells |
| US11951186B2 (en) | 2019-10-25 | 2024-04-09 | Willow Laboratories, Inc. | Indicator compounds, devices comprising indicator compounds, and methods of making and using the same |
| IL273038B (en) | 2020-03-03 | 2022-02-01 | Ben Zion Karmon | bone graft |
| EP4543392A1 (en) | 2022-06-23 | 2025-04-30 | Augustine Biomedical and Design, LLC | Patient securement system for the surgical trendelenburg position |
| US11844733B1 (en) | 2022-06-23 | 2023-12-19 | Augustine Biomedical And Design, Llc | Patient securement system for the surgical Trendelenburg position |
| US20240260861A1 (en) * | 2023-02-06 | 2024-08-08 | Senseonics, Incorporated | Reduction of in vivo analyte signal degradation using multiple metals |
| CN116392648B (zh) * | 2023-04-14 | 2024-08-23 | 中国科学院长春应用化学研究所 | 一种温度、炎症双响应性的抗凝复合涂层及其制备方法、应用 |
| US12453494B1 (en) | 2024-04-12 | 2025-10-28 | Glucotrack, Inc. | Methods and systems for measuring glucose having improved decay rates and lag times |
Family Cites Families (63)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63291595A (ja) | 1987-05-22 | 1988-11-29 | Meidensha Electric Mfg Co Ltd | 生体試料中のグルコ−スの測定方法 |
| US5517313A (en) | 1995-02-21 | 1996-05-14 | Colvin, Jr.; Arthur E. | Fluorescent optical sensor |
| US5772864A (en) | 1996-02-23 | 1998-06-30 | Meadox Medicals, Inc. | Method for manufacturing implantable medical devices |
| US5833603A (en) | 1996-03-13 | 1998-11-10 | Lipomatrix, Inc. | Implantable biosensing transponder |
| US20050033132A1 (en) | 1997-03-04 | 2005-02-10 | Shults Mark C. | Analyte measuring device |
| US8527026B2 (en) | 1997-03-04 | 2013-09-03 | Dexcom, Inc. | Device and method for determining analyte levels |
| US5917605A (en) | 1997-05-13 | 1999-06-29 | Colvin, Jr.; Arthur E. | Fluorescence sensing device |
| US5910661A (en) | 1997-05-13 | 1999-06-08 | Colvin, Jr.; Arthur E. | Flourescence sensing device |
| US5894351A (en) | 1997-05-13 | 1999-04-13 | Colvin, Jr.; Arthur E. | Fluorescence sensing device |
| US5922183A (en) | 1997-06-23 | 1999-07-13 | Eic Laboratories, Inc. | Metal oxide matrix biosensors |
| ATE278352T1 (de) | 1997-08-09 | 2004-10-15 | Roche Diagnostics Gmbh | Analysevorrichtung zur in-vivo-analyse im körper eines patienten |
| KR100718953B1 (ko) | 1998-03-11 | 2007-05-16 | 센서즈 포 메드슨 앤드 사이언스 인코포레이티드 | 형광성 란타니드 킬레이트에 의한 검체의 분석 |
| US6304766B1 (en) * | 1998-08-26 | 2001-10-16 | Sensors For Medicine And Science | Optical-based sensing devices, especially for in-situ sensing in humans |
| AU770909B2 (en) | 1998-08-26 | 2004-03-04 | Sensors For Medicine And Science, Inc. | Optical-based sensing devices |
| DE19855421C2 (de) * | 1998-11-02 | 2001-09-20 | Alcove Surfaces Gmbh | Implantat |
| US6189536B1 (en) * | 1999-04-15 | 2001-02-20 | Medtronic Inc. | Method for protecting implantable devices |
| US7553280B2 (en) | 2000-06-29 | 2009-06-30 | Sensors For Medicine And Science, Inc. | Implanted sensor processing system and method |
| US6400974B1 (en) | 2000-06-29 | 2002-06-04 | Sensors For Medicine And Science, Inc. | Implanted sensor processing system and method for processing implanted sensor output |
| CA2415338C (en) | 2000-08-04 | 2012-10-23 | Sensors For Medicine And Science, Inc. | Detection of analytes in aqueous environments |
| US7470420B2 (en) | 2000-12-05 | 2008-12-30 | The Regents Of The University Of California | Optical determination of glucose utilizing boronic acid adducts |
| US6800451B2 (en) | 2001-01-05 | 2004-10-05 | Sensors For Medicine And Science, Inc. | Detection of glucose in solutions also containing an alpha-hydroxy acid or a beta-diketone |
| EP1386140A1 (en) | 2001-05-04 | 2004-02-04 | Sensors for Medicine and Science, Inc. | Electro-optical sensing device with reference channel |
| TWI293363B (en) | 2001-12-11 | 2008-02-11 | Sensors For Med & Science Inc | High performance fluorescent optical sensor |
| KR20030055609A (ko) | 2001-12-27 | 2003-07-04 | 김재열 | 꼬임 방지형 원주 자동 용접장치 |
| SE0200269D0 (sv) | 2002-01-31 | 2002-01-31 | Ellem Bioteknik Ab | Material for implantation |
| US10022078B2 (en) | 2004-07-13 | 2018-07-17 | Dexcom, Inc. | Analyte sensor |
| AU2003245862A1 (en) | 2002-07-12 | 2004-02-02 | Novo Nordisk A/S | Minimising calibration problems of in vivo glucose sensors |
| JP2006523843A (ja) | 2003-04-15 | 2006-10-19 | センサーズ・フォー・メデセン・アンド・サイエンス・インコーポレーテッド | 光センサーに対する周辺光の影響を減じるための装置及び方法 |
| US7467003B2 (en) | 2003-12-05 | 2008-12-16 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
| US7519408B2 (en) | 2003-11-19 | 2009-04-14 | Dexcom, Inc. | Integrated receiver for continuous analyte sensor |
| US20050095174A1 (en) * | 2003-10-31 | 2005-05-05 | Wolf David E. | Semipermeable sensors for detecting analyte |
| JP2007512859A (ja) * | 2003-11-03 | 2007-05-24 | マイクロチップス・インコーポレーテッド | グルコースを感知するための医療デバイス |
| EP2316331B1 (en) | 2003-12-09 | 2016-06-29 | Dexcom, Inc. | Signal processing for continuous analyte sensor |
| US8165651B2 (en) * | 2004-02-09 | 2012-04-24 | Abbott Diabetes Care Inc. | Analyte sensor, and associated system and method employing a catalytic agent |
| JP2005315871A (ja) | 2004-03-31 | 2005-11-10 | Terumo Corp | 体内物質測定用構成物、体内物質測定用構成物の製造方法、および埋込型物質センサー |
| US7450980B2 (en) | 2004-03-31 | 2008-11-11 | Terumo Kabushiki Kaisha | Intracorporeal substance measuring assembly |
| US7713745B2 (en) | 2004-04-13 | 2010-05-11 | Sensors For Medicine And Science, Inc. | Non-covalent immobilization of indicator molecules |
| US20050234316A1 (en) | 2004-04-16 | 2005-10-20 | Sensors For Medicine And Science, Inc. | Housing for a circuit that is to be implanted in-vivo and process of making the same |
| US7375347B2 (en) | 2004-04-26 | 2008-05-20 | Sensors For Medicine And Science, Inc. | Systems and methods for extending the useful life of optical sensors |
| US7783333B2 (en) * | 2004-07-13 | 2010-08-24 | Dexcom, Inc. | Transcutaneous medical device with variable stiffness |
| US8073548B2 (en) | 2004-08-24 | 2011-12-06 | Sensors For Medicine And Science, Inc. | Wristband or other type of band having an adjustable antenna for use with a sensor reader |
| US8308794B2 (en) * | 2004-11-15 | 2012-11-13 | IZEK Technologies, Inc. | Instrumented implantable stents, vascular grafts and other medical devices |
| US7308292B2 (en) | 2005-04-15 | 2007-12-11 | Sensors For Medicine And Science, Inc. | Optical-based sensing devices |
| WO2006133305A2 (en) | 2005-06-08 | 2006-12-14 | Sensors For Medicine And Science, Inc. | Insertion device and method |
| US20070014726A1 (en) * | 2005-07-18 | 2007-01-18 | Sensors For Medicine And Science | Oxidation-resistant indicator macromolecule |
| EP1790977A1 (en) | 2005-11-23 | 2007-05-30 | SONY DEUTSCHLAND GmbH | Nanoparticle/nanofiber based chemical sensor, arrays of such sensors, uses and method of fabrication thereof, and method of detecting an analyte |
| WO2007110867A2 (en) * | 2006-03-28 | 2007-10-04 | Glusense Ltd. | Implantable sensor |
| US20080125838A1 (en) | 2006-08-10 | 2008-05-29 | Medtronic, Inc. | Implantable Devices With Photocatalytic Surfaces |
| DK2099807T3 (da) | 2006-11-30 | 2014-01-27 | Senseonics Inc | Oxidationsresistente indikatormolekyler |
| CN101657911B (zh) | 2007-03-08 | 2011-11-16 | 医药及科学传感器公司 | 用于恶劣环境的发光二极管 |
| JP5517919B2 (ja) * | 2007-05-10 | 2014-06-11 | グルメトリクス、 インク． | 即時血管内グルコース測定のための平衡非消費蛍光センサー |
| MX2011001114A (es) | 2008-07-28 | 2011-04-21 | Sensors For Med & Science Inc | Sistemas y metodos para la medicion optica de la concentracion de analitos. |
| EP2326944B1 (en) | 2008-09-19 | 2020-08-19 | Dexcom, Inc. | Particle-containing membrane and particulate electrode for analyte sensors |
| US20120251586A1 (en) | 2009-04-09 | 2012-10-04 | The Children's Hospital Of Philadelphia | Ligand-specific inhibition of attachment of immune cells to implantable biomaterials |
| TW201041612A (en) | 2009-04-21 | 2010-12-01 | Sensors For Med & Science Inc | Protective shell for an in vivo sensor made from resorbable polymer |
| US8940544B2 (en) | 2010-02-08 | 2015-01-27 | Medtronic Minimed, Inc. | Antioxidant protection of a chemical sensor |
| EP2537034B1 (en) | 2010-02-16 | 2019-01-02 | Lightship Medical Limited | Barrier layer for glucose sensor |
| JP5101659B2 (ja) * | 2010-05-25 | 2012-12-19 | 株式会社東芝 | 血圧センサ |
| US20120053427A1 (en) * | 2010-08-31 | 2012-03-01 | Glumetrics, Inc. | Optical sensor configuration and methods for monitoring glucose activity in interstitial fluid |
| KR101690535B1 (ko) | 2010-10-06 | 2017-01-09 | 프로퓨사 인코퍼레이티드 | 조직-일체화 센서 |
| AU2012229109A1 (en) | 2011-03-15 | 2013-10-10 | Senseonics, Incorporated | Integrated catalytic protection of oxidation sensitive materials |
| WO2013024260A1 (en) | 2011-08-17 | 2013-02-21 | Lightship Medical Limited | Barrier layer for glucose sensor |
| AU2013234126A1 (en) | 2012-03-15 | 2014-09-25 | Lightship Medical Limited | Sensor for detecting the amount of analyte in a sample |
-
2012
- 2012-03-15 AU AU2012229109A patent/AU2012229109A1/en not_active Abandoned
- 2012-03-15 CN CN201280023591.3A patent/CN103533884B/zh not_active Expired - Fee Related
- 2012-03-15 JP JP2013558170A patent/JP6084172B2/ja not_active Expired - Fee Related
- 2012-03-15 KR KR1020137027216A patent/KR101959067B1/ko not_active Expired - Fee Related
- 2012-03-15 TW TW101109012A patent/TWI592663B/zh not_active IP Right Cessation
- 2012-03-15 EP EP12757630.4A patent/EP2685884B1/en active Active
- 2012-03-15 WO PCT/US2012/029209 patent/WO2012125814A2/en not_active Ceased
- 2012-03-15 SG SG2013069745A patent/SG193496A1/en unknown
- 2012-03-15 US US13/421,013 patent/US9681824B2/en active Active
- 2012-03-15 CA CA2830432A patent/CA2830432C/en active Active
-
2017
- 2017-06-15 US US15/623,474 patent/US10674937B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2685884B1 (en) | 2020-09-23 |
| TWI592663B (zh) | 2017-07-21 |
| US20180146885A1 (en) | 2018-05-31 |
| AU2012229109A1 (en) | 2013-10-10 |
| EP2685884A2 (en) | 2014-01-22 |
| CN103533884B (zh) | 2016-06-01 |
| TW201243332A (en) | 2012-11-01 |
| KR20140035892A (ko) | 2014-03-24 |
| EP2685884A4 (en) | 2015-04-15 |
| SG193496A1 (en) | 2013-10-30 |
| WO2012125814A3 (en) | 2013-12-27 |
| US10674937B2 (en) | 2020-06-09 |
| CA2830432C (en) | 2022-04-26 |
| WO2012125814A2 (en) | 2012-09-20 |
| CN103533884A (zh) | 2014-01-22 |
| KR101959067B1 (ko) | 2019-03-15 |
| US9681824B2 (en) | 2017-06-20 |
| US20120238842A1 (en) | 2012-09-20 |
| JP2014514033A (ja) | 2014-06-19 |
| CA2830432A1 (en) | 2012-09-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6084172B2 (ja) | 酸化感受性材料の統合的な触媒による保護 | |
| US20170202517A1 (en) | Integrated catalytic protection of oxidation sensitive materials | |
| US20200337619A1 (en) | Bio-adaptable implantable sensor apparatus and methods | |
| Corsi et al. | Bioresorbable nanostructured chemical sensor for monitoring of pH level in vivo | |
| DK2043511T3 (en) | Methods and Materials for Stabilizing Analyte Sensors | |
| DE60008517T2 (de) | Derivatisiertes poröses silicium | |
| Colvin et al. | Increased in vivo stability and functional lifetime of an implantable glucose sensor through platinum catalysis | |
| CN109419515B (zh) | 具有分级激活的可植入化学传感器 | |
| US20100298674A1 (en) | Protective shell for an in vivo sensor made from resorbable polymer | |
| US20130213110A1 (en) | Control of biofouling in implantable biosensors | |
| WO2003011354A3 (en) | Membrane for use with implantable devices | |
| Uzair et al. | Noninvasively imaging pH at the surface of implanted orthopedic devices with X-ray excited luminescence chemical imaging | |
| Wang et al. | Effect of dexamethasone-loaded poly (lactic-co-glycolic acid) microsphere/poly (vinyl alcohol) hydrogel composite coatings on the basic characteristics of implantable glucose sensors | |
| Vaddiraju et al. | Needle-implantable, wireless biosensor for continuous glucose monitoring | |
| US20240260861A1 (en) | Reduction of in vivo analyte signal degradation using multiple metals | |
| Frost et al. | In vivo sensors for continuous monitoring of blood gases, glucose, and lactate: biocompatibility challenges and potential solutions | |
| JP2022506601A (ja) | 分析物指示薬上の薬剤溶出マトリクス |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150303 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20150303 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20160127 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20160129 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20160427 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20160627 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160727 |
|
| A524 | Written submission of copy of amendment under article 19 pct |
Free format text: JAPANESE INTERMEDIATE CODE: A524 Effective date: 20160727 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20161226 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20170124 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6084172 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| LAPS | Cancellation because of no payment of annual fees |